UK Oxford Timm K: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
|Contact=Timm Kerstin | |Contact=Timm Kerstin | ||
|Status=O2k 2021- | |Status=O2k 2021- | ||
|info=[[MiPNet25.16 Virtual O2k-Workshop HRR| Virtual O2k-Workshop]] | |||
|keyword=Cardio-oncology, namely in the side effects of chemotherapy on the heart. Particularly interested in how different classes of chemotherapeutics affect cardiac metabolism and energetics, and how cardioprotective agents may interfere with, or potentiate, anti-cancer action of chemotherapeutics.Use the O2k for HRR of cardiac muscle fibres, isolated cardiac mitochondria, tumour homogenates and cardiomyocytes and cancer cells. Have collaborations in neuropharmacology and are happy to discuss potential collaborations across disciplines | |keyword=Cardio-oncology, namely in the side effects of chemotherapy on the heart. Particularly interested in how different classes of chemotherapeutics affect cardiac metabolism and energetics, and how cardioprotective agents may interfere with, or potentiate, anti-cancer action of chemotherapeutics.Use the O2k for HRR of cardiac muscle fibres, isolated cardiac mitochondria, tumour homogenates and cardiomyocytes and cancer cells. Have collaborations in neuropharmacology and are happy to discuss potential collaborations across disciplines | ||
}} | }} | ||
Latest revision as of 10:39, 8 November 2022
UK Oxford Timm K
| O2k-Network Lab | University of Oxford, Department of Pharmacology |
|---|---|
| Address | Mansfield Road, OX1 3QT |
| City | Oxford |
| State/Prov | |
| Country | United Kingdom |
| Weblink | https://www.pharm.ox.ac.uk/research/timm-group |
| Contact | Timm Kerstin |
| Team | |
| Team previous | |
| Status | O2k 2021- |
| Oroboros Events | Virtual O2k-Workshop |
| Topics | Cardio-oncology, namely in the side effects of chemotherapy on the heart. Particularly interested in how different classes of chemotherapeutics affect cardiac metabolism and energetics, and how cardioprotective agents may interfere with, or potentiate, anti-cancer action of chemotherapeutics.Use the O2k for HRR of cardiac muscle fibres, isolated cardiac mitochondria, tumour homogenates and cardiomyocytes and cancer cells. Have collaborations in neuropharmacology and are happy to discuss potential collaborations across disciplines |
O2k-Publications
update please
O2k-Abstracts
update please
